RIGANTI, Chiara
Dettaglio
RIGANTI, Chiara
ONCOLOGIA
Pubblicazioni
Risultati 1 - 20 di 304 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers | 2020 | Braconi L.; Bartolucci G.; Contino M.; Chiaramonte N.; Giampietro R.; Manetti D.; Perrone M.G.; Romanelli M.N.; Colabufo N.A.; Riganti C.; Dei S.; Teodori E. |
2 | ABCA1, apoA-I, and BTN3A1: A Legitimate ménage à trois in dendritic cells | 2018 | Riganti, Chiara; Castella, Barbara; Massaia, Massimo |
3 | ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma | 2020 | Belisario, Dimas Carolina; Akman, Muhlis; Godel, Martina; Campani, Virginia; Patrizio, Maria Pia; Scotti, Lorena; Hattinger, Claudia Maria; De Rosa, Giuseppe De; Donadelli, Massimo; Serra, Massimo; Kopecka, Joanna; Riganti, Chiara |
4 | Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta |
5 | Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth | 2015 | Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco |
6 | Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia |
7 | Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations | 2018 | Magliocca, Salvatore; De Caro, Carmen; Lazzarato, Loretta; Russo, Roberto; Rolando, Barbara; Chegaev, Konstantin; Marini, Elisabetta; Nieddu, Maria; Burrai, Lucia; Boatto, Gianpiero; Cristiano, Claudia; Marabello, Domenica; Gazzano, Elena; Riganti, Chiara; Sodano, Federica; Rimoli, Maria Grazia |
8 | Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells | 2008 | Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A |
9 | Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis | 2017 | Principe, Moitza; Borgoni, Simone; Cascione, Mariafrancesca; Chattaragada, Michelle Samuel; Ferri-Borgogno, Sammy; Capello, Michela; Bulfamante, Sara; Chapelle, Jennifer; Di Modugno, Francesca; Defilippi, Paola; Nisticò, Paola; Cappello, Paola; Riganti, Chiara; Leporatti, Stefano; Novelli, Francesco |
10 | Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma | 2015 | Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M. |
11 | Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma | 2019 | Villanova, Tania; Gesmundo, Iacopo; Audrito, Valentina; Vitale, Nicoletta; Silvagno, Francesca; Musuraca, Chiara; Righi, Luisella; Libener, Roberta; Riganti, Chiara; Bironzo, Paolo; Deaglio, Silvia; Papotti, Mauro; Cai, Renzhi; Sha, Wei; Ghigo, Ezio; Schally, Andrew V; Granata, Riccarda |
12 | Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells | 2011 | E. Gazzano; E. Aldieri; C. Riganti; F. Silvagno; S. Orecchia; P.G. Betta; S. Doublier; M. Polimeni; A. Bosia; D. Ghigo |
13 | Antioxidants Prevent the RhoA Inhibition Evoked by Crocidolite Asbestos in Human Mesothelial and Mesothelioma Cells. | 2011 | Aldieri E; Riganti C; Silvagno F; Orecchia S; Betta PG; Doublier S; Gazzano E; Polimeni M; Bosia A; Ghigo D. |
14 | Applicability and limitations in the characterization of poly-dispersed engineered nanomaterials in cell media by dinamic light scattering (DLS) | 2019 | Arianna Marucco, Elisabetta Aldieri, Riccardo Leinardi, Enrico Bergamaschi, Chiara Riganti, Ivana Fenoglio |
15 | Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression | 2009 | Riganti C; Doublier S; Viarisio D; Miraglia E; Pescarmona G; Ghigo D; Bosia A |
16 | Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation | 2003 | ALDIERI E.; ATRAGENE D.; BERGANDI L.; RIGANTI C.; COSTAMAGNA C.; A. BOSIA; GHIGO D. |
17 | Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha | 2008 | Riganti C; Doublier S; Aldieri E; Orecchia S; Betta PG; Gazzano E; Ghigo D; Bosia A |
18 | Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition | 2007 | RIGANTI C; ORECCHIA S; SILVAGNO F; PESCARMONA GP; BETTA PG; GAZZANO E; ALDIERI E; GHIGO D; BOSIA A |
19 | Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. | 2011 | Riganti C; Pinto H; Bolli E; Belisario DC; Calogero RA; Bosia A; Cavallo F |
20 | The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells | 2017 | Castella, Barbara; Kopecka, Joanna; Sciancalepore, Patrizia; Mandili, Giorgia; Foglietta, Myriam; Mitro, Nico; Caruso, Donatella; Novelli, Francesco; Riganti, Chiara; Massaia, Massimo |